Religare Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 24, 2025, 9:04 pm

Market Cap	7,188 Cr.
Current Price	218
High / Low	320/201
Stock P/E	245
Book Value	74.1
Dividend Yield	0.00 %
ROCE	9.24 %
ROE	5.32 %
Face Value	10.0
PEG Ratio	2.70

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Religare Enterprises Ltd

Competitors of Religare Enterprises Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
MKVentures Capital Ltd	609 Cr.	1,584	2,800/1,151	29.6	267	0.06 %	20.6 %	33.6 %	10.0
Modern Shares & Stockbrokers Ltd	12.8 Cr.	43.7	69.4/39.5	36.6	43.9	0.00 %	4.33 %	3.24 %	10.0
Monarch Networth Capital Ltd	2,582 Cr.	330	501/226	16.6	93.0	0.15 %	51.8 %	43.4 %	10.0
Monotype India Ltd	55.5 Cr.	0.79	2.42/0.67	6.95	0.13	0.00 %	438 %	%	1.00
Multipurpose Trading & Agencies Ltd	4.92 Cr.	9.95	13.3/7.93	25.9	10.2	0.00 %	4.44 %	3.91 %	10.0
Industry Average	6,429.10 Cr	1,437.10		89.57	5,265.37	0.34%	18.78%	17.28%	7.38

All Competitor Stocks of Religare Enterprises Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	827	953	951	1,164	1,165	1,396	1,285	1,584	1,511	1,856	1,710	1,952	1,664
Expenses	921	824	923	1,117	1,020	1,149	1,147	1,483	1,455	1,833	1,653	1,876	1,730
Operating Profit	-94	128	28	47	145	247	138	101	56	23	57	76	-66
OPM %	-11%	13%	3%	4%	12%	18%	11%	6%	4%	1%	3%	4%	-4%
Other Income	54	3	101	19	3	3,354	18	1	27	249	5	19	6
Interest	197	181	189	197	213	29	26	25	24	18	13	13	5
Depreciation	14	14	14	13	14	14	19	18	18	17	16	15	14
Profit before tax	-250	-63	-75	-144	-79	3,557	112	59	41	236	33	67	-79
Tax %	0%	826%	1%	22%	22%	1%	17%	32%	18%	23%	18%	-2%	-20%
Net Profit	-251	-588	-76	-177	-96	3,517	93	40	34	181	27	68	-63
EPS in Rs	-7.84	-19.20	-2.38	-6.49	-3.62	107.61	1.94	0.78	0.59	3.80	0.55	1.55	-1.30

Last Updated: February 28, 2025, 5:30 pm

Below is a detailed analysis of the quarterly data for Religare Enterprises Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 1,664.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,952.00 Cr. (Sep 2024) to 1,664.00 Cr., marking a decrease of 288.00 Cr..
For Expenses, as of Dec 2024, the value is 1,730.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,876.00 Cr. (Sep 2024) to 1,730.00 Cr., marking a decrease of 146.00 Cr..
For Operating Profit, as of Dec 2024, the value is -66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 76.00 Cr. (Sep 2024) to -66.00 Cr., marking a decrease of 142.00 Cr..
For OPM %, as of Dec 2024, the value is -4.00%. The value appears to be declining and may need further review. It has decreased from 4.00% (Sep 2024) to -4.00%, marking a decrease of 8.00%.
For Other Income, as of Dec 2024, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 19.00 Cr. (Sep 2024) to 6.00 Cr., marking a decrease of 13.00 Cr..
For Interest, as of Dec 2024, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 13.00 Cr. (Sep 2024) to 5.00 Cr., marking a decrease of 8.00 Cr..
For Depreciation, as of Dec 2024, the value is 14.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 15.00 Cr. (Sep 2024) to 14.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is -79.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Sep 2024) to -79.00 Cr., marking a decrease of 146.00 Cr..
For Tax %, as of Dec 2024, the value is -20.00%. The value appears to be improving (decreasing) as expected. It has decreased from -2.00% (Sep 2024) to -20.00%, marking a decrease of 18.00%.
For Net Profit, as of Dec 2024, the value is -63.00 Cr.. The value appears to be declining and may need further review. It has decreased from 68.00 Cr. (Sep 2024) to -63.00 Cr., marking a decrease of 131.00 Cr..
For EPS in Rs, as of Dec 2024, the value is -1.30. The value appears to be declining and may need further review. It has decreased from 1.55 (Sep 2024) to -1.30, marking a decrease of 2.85.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 7:02 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	3,762	3,361	4,128	4,895	3,709	2,675	2,371	2,384	2,513	3,227	4,679	6,266	7,182
Expenses	1,460	1,585	2,006	3,710	1,659	2,841	3,005	2,341	2,235	3,592	4,196	5,898	7,091
Operating Profit	2,302	1,775	2,122	1,184	2,050	-167	-634	43	278	-364	483	368	90
OPM %	61%	53%	51%	24%	55%	-6%	-27%	2%	11%	-11%	10%	6%	1%
Other Income	-777	25	58	1,012	-316	60	10	-157	17	137	3,473	263	279
Interest	1,722	1,584	1,658	1,879	1,840	1,271	854	855	733	750	641	112	50
Depreciation	60	34	37	36	31	30	26	61	59	53	56	72	62
Profit before tax	-258	182	485	282	-136	-1,407	-1,504	-1,030	-497	-1,031	3,259	448	258
Tax %	87%	85%	34%	79%	-10%	-16%	-0%	1%	-4%	49%	3%	22%
Net Profit	-481	27	321	61	-124	-1,181	-1,501	-1,038	-478	-1,539	3,169	347	213
EPS in Rs	-37.09	-4.63	8.62	-2.67	-9.77	-58.56	-59.33	-36.12	-19.60	-48.43	95.24	7.06	4.60
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	105.61%	1088.89%	-81.00%	-303.28%	-852.42%	-27.10%	30.85%	53.95%	-221.97%	305.91%	-89.05%
Change in YoY Net Profit Growth (%)	0.00%	983.28%	-1169.89%	-222.28%	-549.14%	825.32%	57.94%	23.10%	-275.92%	527.88%	-394.96%

Religare Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	6%
5 Years:	21%
3 Years:	36%
TTM:	24%

Compounded Profit Growth
10 Years:	11%
5 Years:	16%
3 Years:	31%
TTM:	-92%

Stock Price CAGR
10 Years:	-5%
5 Years:	54%
3 Years:	19%
1 Year:	-2%

Return on Equity
10 Years:	%
5 Years:	%
3 Years:	%
Last Year:	5%

Last Updated: Unknown

Balance Sheet

Last Updated: December 14, 2024, 2:52 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	149	150	178	178	178	178	217	258	259	319	324	330	330
Reserves	2,970	2,982	3,705	3,660	2,549	1,658	616	-157	-306	-1,301	1,734	2,013	2,121
Borrowings	13,421	14,073	16,491	20,247	14,956	9,945	6,717	5,356	4,940	4,878	841	443	206
Other Liabilities	3,755	3,920	5,064	3,344	3,355	2,081	2,023	2,673	3,832	5,467	5,193	6,789	7,620
Total Liabilities	20,295	21,125	25,439	27,429	21,038	13,862	9,573	8,130	8,725	9,362	8,092	9,575	10,276
Fixed Assets	1,822	1,981	2,128	1,785	103	80	83	175	117	127	196	161	157
CWIP	4	12	4	4	12	11	14	13	12	2	5	6	0
Investments	2,419	3,344	4,363	2,700	1,983	1,197	1,438	2,023	3,190	3,836	5,094	6,718	7,584
Other Assets	16,049	15,788	18,944	22,941	18,940	12,574	8,038	5,919	5,406	5,397	2,797	2,690	2,536
Total Assets	20,295	21,125	25,439	27,429	21,038	13,862	9,573	8,130	8,725	9,362	8,092	9,575	10,276

Below is a detailed analysis of the balance sheet data for Religare Enterprises Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹330.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 330.00 Cr..
For Reserves, as of Sep 2024, the value is ₹2,121.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,013.00 Cr. (Mar 2024) to ₹2,121.00 Cr., marking an increase of 108.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹206.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 443.00 Cr. (Mar 2024) to ₹206.00 Cr., marking a decrease of 237.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹7,620.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6,789.00 Cr. (Mar 2024) to ₹7,620.00 Cr., marking an increase of 831.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹10,276.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 9,575.00 Cr. (Mar 2024) to ₹10,276.00 Cr., marking an increase of 701.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹157.00 Cr.. The value appears to be declining and may need further review. It has decreased from 161.00 Cr. (Mar 2024) to ₹157.00 Cr., marking a decrease of 4.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 6.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 6.00 Cr..
For Investments, as of Sep 2024, the value is ₹7,584.00 Cr.. The value appears strong and on an upward trend. It has increased from 6,718.00 Cr. (Mar 2024) to ₹7,584.00 Cr., marking an increase of 866.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹2,536.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,690.00 Cr. (Mar 2024) to ₹2,536.00 Cr., marking a decrease of 154.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹10,276.00 Cr.. The value appears strong and on an upward trend. It has increased from 9,575.00 Cr. (Mar 2024) to ₹10,276.00 Cr., marking an increase of 701.00 Cr..

Notably, the Reserves (2,121.00 Cr.) exceed the Borrowings (206.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	2,936	1,634	-706	-2,154	5,871	5,802	3,555	2,433	1,373	1,596	1,506	1,500
Cash from Investing Activity +	-730	-403	-612	499	2,149	-457	-31	-436	-1,181	-689	-939	-1,348
Cash from Financing Activity +	-2,326	-1,400	1,094	1,853	-7,696	-6,455	-3,819	-1,743	-314	559	-2,079	-156
Net Cash Flow	-120	-169	-224	198	324	-1,110	-295	254	-122	1,466	-1,512	-4

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-11.00	-13.00	-14.00	-19.00	-12.00	-176.00	-640.00	38.00	274.00	-368.00	-358.00	-75.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	47	52	52	35	60	42	53	14	28	21	14	14
Inventory Days
Days Payable
Cash Conversion Cycle	47	52	52	35	60	42	53	14	28	21	14	14
Working Capital Days	265	104	56	42	26	-118	-98	-267	-264	-387	-275	-291
ROCE %	11%	11%	11%	9%	10%	-1%	-7%	-0%	4%	-6%	16%	9%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
FIIs	19.59%	18.99%	19.60%	18.79%	18.30%	19.48%	11.75%	9.89%	7.91%	8.49%	8.01%	8.05%
DIIs	2.38%	3.82%	5.63%	7.18%	7.42%	7.00%	7.84%	7.75%	8.17%	10.99%	13.43%	13.14%
Public	78.03%	77.19%	74.77%	74.02%	74.27%	73.52%	80.41%	82.36%	83.92%	80.51%	78.56%	78.82%
No. of Shareholders	57,189	55,613	55,222	59,752	59,292	57,939	61,535	69,311	84,527	83,050	79,946	80,236

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
Motilal Oswal Large and Midcap Fund	3,000,000	2.48	67.58	3,000,000	2025-04-22 15:56:54	0%
Motilal Oswal ELSS Tax Saver Fund	2,900,000	2.37	65.32	2,900,000	2025-04-22 15:56:54	0%
Motilal Oswal Balance Advantage Fund	2,740,728	7.4	61.73	2,740,728	2025-04-22 15:56:54	0%
Motilal Oswal Focused Fund	2,022,299	2.56	45.55	2,022,299	2025-04-22 17:25:21	0%
Motilal Oswal Equity Hybrid Fund	894,303	4.7	20.14	894,303	2025-04-22 15:56:54	0%
Motilal Oswal Nifty Microcap 250 Index Fund	340,598	1.34	7.67	340,598	2025-04-22 15:56:54	0%
Motilal Oswal Multi Asset Fund	250,000	5.12	5.63	250,000	2025-04-22 17:25:21	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	7.13	96.06	-51.33	-19.65	-39.55
Diluted EPS (Rs.)	7.07	94.67	-51.33	-19.65	-39.62
Cash EPS (Rs.)	12.71	99.67	-46.58	-16.15	-37.85
Book Value[Excl.RevalReserv]/Share (Rs.)	96.28	82.75	-16.69	11.48	7.53
Book Value[Incl.RevalReserv]/Share (Rs.)	96.28	82.75	-16.69	11.48	7.53
Revenue From Operations / Share (Rs.)	189.09	144.53	101.11	95.86	91.25
PBDIT / Share (Rs.)	11.60	20.20	-7.46	11.04	1.94
PBIT / Share (Rs.)	9.43	18.46	-9.14	8.77	-0.41
PBT / Share (Rs.)	13.58	100.71	-32.34	-19.17	-39.90
Net Profit / Share (Rs.)	10.54	97.93	-48.26	-18.41	-40.21
NP After MI And SOA / Share (Rs.)	3.47	95.24	-48.43	-19.60	-36.12
PBDIT Margin (%)	6.13	13.97	-7.38	11.51	2.12
PBIT Margin (%)	4.98	12.77	-9.03	9.15	-0.45
PBT Margin (%)	7.18	69.68	-31.98	-20.00	-43.72
Net Profit Margin (%)	5.57	67.75	-47.72	-19.21	-44.06
NP After MI And SOA Margin (%)	1.83	65.89	-47.89	-20.44	-39.58
Return on Networth / Equity (%)	4.88	149.76	0.00	0.00	-923.09
Return on Capital Employeed (%)	4.56	10.92	-19.54	10.06	-0.61
Return On Assets (%)	1.19	38.07	-16.50	-5.82	-11.46
Long Term Debt / Equity (X)	0.00	0.00	0.00	-11.92	5.59
Total Debt / Equity (X)	0.14	0.35	-4.92	-103.85	53.02
Asset Turnover Ratio (%)	0.70	0.00	0.00	0.00	0.00
Current Ratio (X)	3.25	2.81	1.11	1.16	1.08
Quick Ratio (X)	3.25	2.81	1.11	1.16	1.08
Interest Coverage Ratio (X)	4.09	1.04	-0.32	0.39	0.05
Interest Coverage Ratio (Post Tax) (X)	2.25	0.80	-1.08	0.34	-0.02
Enterprise Value (Cr.)	7005.91	5230.88	7032.76	5988.22	4485.50
EV / Net Operating Revenue (X)	1.12	1.12	2.18	2.41	1.90
EV / EBITDA (X)	18.31	8.01	-29.55	20.91	89.49
MarketCap / Net Operating Revenue (X)	1.11	1.00	1.29	0.91	0.20
Price / BV (X)	2.95	2.28	-4.22	-48.26	4.86
Price / Net Operating Revenue (X)	1.11	1.00	1.29	0.91	0.20
EarningsYield	0.01	0.65	-0.37	-0.22	-1.90

After reviewing the key financial ratios for Religare Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 7.13. This value is within the healthy range. It has decreased from 96.06 (Mar 23) to 7.13, marking a decrease of 88.93.
For Diluted EPS (Rs.), as of Mar 24, the value is 7.07. This value is within the healthy range. It has decreased from 94.67 (Mar 23) to 7.07, marking a decrease of 87.60.
For Cash EPS (Rs.), as of Mar 24, the value is 12.71. This value is within the healthy range. It has decreased from 99.67 (Mar 23) to 12.71, marking a decrease of 86.96.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 96.28. It has increased from 82.75 (Mar 23) to 96.28, marking an increase of 13.53.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 96.28. It has increased from 82.75 (Mar 23) to 96.28, marking an increase of 13.53.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 189.09. It has increased from 144.53 (Mar 23) to 189.09, marking an increase of 44.56.
For PBDIT / Share (Rs.), as of Mar 24, the value is 11.60. This value is within the healthy range. It has decreased from 20.20 (Mar 23) to 11.60, marking a decrease of 8.60.
For PBIT / Share (Rs.), as of Mar 24, the value is 9.43. This value is within the healthy range. It has decreased from 18.46 (Mar 23) to 9.43, marking a decrease of 9.03.
For PBT / Share (Rs.), as of Mar 24, the value is 13.58. This value is within the healthy range. It has decreased from 100.71 (Mar 23) to 13.58, marking a decrease of 87.13.
For Net Profit / Share (Rs.), as of Mar 24, the value is 10.54. This value is within the healthy range. It has decreased from 97.93 (Mar 23) to 10.54, marking a decrease of 87.39.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 3.47. This value is within the healthy range. It has decreased from 95.24 (Mar 23) to 3.47, marking a decrease of 91.77.
For PBDIT Margin (%), as of Mar 24, the value is 6.13. This value is below the healthy minimum of 10. It has decreased from 13.97 (Mar 23) to 6.13, marking a decrease of 7.84.
For PBIT Margin (%), as of Mar 24, the value is 4.98. This value is below the healthy minimum of 10. It has decreased from 12.77 (Mar 23) to 4.98, marking a decrease of 7.79.
For PBT Margin (%), as of Mar 24, the value is 7.18. This value is below the healthy minimum of 10. It has decreased from 69.68 (Mar 23) to 7.18, marking a decrease of 62.50.
For Net Profit Margin (%), as of Mar 24, the value is 5.57. This value is within the healthy range. It has decreased from 67.75 (Mar 23) to 5.57, marking a decrease of 62.18.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 1.83. This value is below the healthy minimum of 8. It has decreased from 65.89 (Mar 23) to 1.83, marking a decrease of 64.06.
For Return on Networth / Equity (%), as of Mar 24, the value is 4.88. This value is below the healthy minimum of 15. It has decreased from 149.76 (Mar 23) to 4.88, marking a decrease of 144.88.
For Return on Capital Employeed (%), as of Mar 24, the value is 4.56. This value is below the healthy minimum of 10. It has decreased from 10.92 (Mar 23) to 4.56, marking a decrease of 6.36.
For Return On Assets (%), as of Mar 24, the value is 1.19. This value is below the healthy minimum of 5. It has decreased from 38.07 (Mar 23) to 1.19, marking a decrease of 36.88.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 23) which recorded 0.00.
For Total Debt / Equity (X), as of Mar 24, the value is 0.14. This value is within the healthy range. It has decreased from 0.35 (Mar 23) to 0.14, marking a decrease of 0.21.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.70. It has increased from 0.00 (Mar 23) to 0.70, marking an increase of 0.70.
For Current Ratio (X), as of Mar 24, the value is 3.25. This value exceeds the healthy maximum of 3. It has increased from 2.81 (Mar 23) to 3.25, marking an increase of 0.44.
For Quick Ratio (X), as of Mar 24, the value is 3.25. This value exceeds the healthy maximum of 2. It has increased from 2.81 (Mar 23) to 3.25, marking an increase of 0.44.
For Interest Coverage Ratio (X), as of Mar 24, the value is 4.09. This value is within the healthy range. It has increased from 1.04 (Mar 23) to 4.09, marking an increase of 3.05.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.25. This value is below the healthy minimum of 3. It has increased from 0.80 (Mar 23) to 2.25, marking an increase of 1.45.
For Enterprise Value (Cr.), as of Mar 24, the value is 7,005.91. It has increased from 5,230.88 (Mar 23) to 7,005.91, marking an increase of 1,775.03.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 1.12. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 1.12.
For EV / EBITDA (X), as of Mar 24, the value is 18.31. This value exceeds the healthy maximum of 15. It has increased from 8.01 (Mar 23) to 18.31, marking an increase of 10.30.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 1.11. This value is within the healthy range. It has increased from 1.00 (Mar 23) to 1.11, marking an increase of 0.11.
For Price / BV (X), as of Mar 24, the value is 2.95. This value is within the healthy range. It has increased from 2.28 (Mar 23) to 2.95, marking an increase of 0.67.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 1.11. This value is within the healthy range. It has increased from 1.00 (Mar 23) to 1.11, marking an increase of 0.11.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.65 (Mar 23) to 0.01, marking a decrease of 0.64.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Religare Enterprises Ltd as of April 25, 2025 is: 788.11

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 25, 2025, Religare Enterprises Ltd is Undervalued by 261.52% compared to the current share price 218.00

Intrinsic Value of Religare Enterprises Ltd as of April 25, 2025 is: 1,502.68

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 25, 2025, Religare Enterprises Ltd is Undervalued by 589.30% compared to the current share price 218.00

Last 5 Year EPS CAGR: 90.67%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -100.58, which is a positive sign. The company has shown consistent growth in sales (3.46 cr) and profit (58.69 cr) over the years.	The stock has a low average ROCE of 5.58%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 36.00, which may not be favorable. The company has higher borrowings (8,654.92) compared to reserves (1,711.08), which may suggest financial risk.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Religare Enterprises Ltd:
1. Net Profit Margin: 5.57%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.56% (Industry Average ROCE: 18.78%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 4.88% (Industry Average ROE: 17.28%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.25
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 3.25
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 245 (Industry average Stock P/E: 89.57)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.14
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Religare Enterprises Ltd. is a Public Limited Listed company incorporated on 30/01/1984 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L74899DL1984PLC146935 and registration number is 146935. Currently Company is involved in the business activities of Activities of holding companies. Company's Total Operating Revenue is Rs. 11.78 Cr. and Equity Capital is Rs. 329.72 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Finance & Investments	1407, 14th Floor, Chiranjiv Tower, New Delhi Delhi 110019	investorservices@religare.com http://www.religare.com

Management
Name	Position Held
Dr. Rashmi Saluja	Executive Chairperson
Mr. Hamid Ahmed	Independent Director
Mr. Praveen Kumar Tripathi	Independent Director
Mr. Malay Kumar Sinha	Independent Director
Mr. Ranjan Dwivedi	Independent Director
Mrs. Preeti Madan	Independent Director

FAQ

What is the intrinsic value of Religare Enterprises Ltd?

Religare Enterprises Ltd's intrinsic value (as of 24 April 2025) is ₹788.11 — 261.52% higher the current market price of 218.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 7,188 Cr. market cap, FY2025-2026 high/low of ₹320/201, reserves of 2,121 Cr, and liabilities of 10,276 Cr.

What is the Market Cap of Religare Enterprises Ltd?

The Market Cap of Religare Enterprises Ltd is 7,188 Cr..

What is the current Stock Price of Religare Enterprises Ltd as on 24 April 2025?

The current stock price of Religare Enterprises Ltd as on 24 April 2025 is 218.

What is the High / Low of Religare Enterprises Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Religare Enterprises Ltd stocks is ₹320/201.

What is the Stock P/E of Religare Enterprises Ltd?

The Stock P/E of Religare Enterprises Ltd is 245.

What is the Book Value of Religare Enterprises Ltd?

The Book Value of Religare Enterprises Ltd is 74.1.

What is the Dividend Yield of Religare Enterprises Ltd?

The Dividend Yield of Religare Enterprises Ltd is 0.00 %.

What is the ROCE of Religare Enterprises Ltd?

The ROCE of Religare Enterprises Ltd is 9.24 %.

What is the ROE of Religare Enterprises Ltd?

The ROE of Religare Enterprises Ltd is 5.32 %.

What is the Face Value of Religare Enterprises Ltd?

The Face Value of Religare Enterprises Ltd is 10.0.